Ida Kim Wium-Andersen1, Maj Vinberg2, Lars Vedel Kessing2, Roger S McIntyre3. 1. a Psychiatric Center Ballerup , Ballerup , Denmark. 2. b Psychiatric Center Copenhagen , Copenhagen University , Copenhagen , Denmark. 3. c Mood Disorders Psychopharmacology Unit , University Health Network , Toronto , ON , Canada.
Abstract
BACKGROUND: Personalized medicine is a model in which a patient's unique clinical, genetic, and environmental characteristics are the basis for treatment and prevention. Aim, method, and results: This review aims to describe the current tools, phenomenological features, clinical risk factors, and biomarkers used to provide personalized medicine. Furthermore, this study describes the target areas in which they can be applied including diagnostics, treatment selection and response, assessment of risk of side-effects, and prevention. DISCUSSION AND CONCLUSION: Personalized medicine in psychiatry is challenged by the current taxonomy, where the diagnostic categories are broad and great biological heterogeneity exists within each category. There is, thus, a gap between the current advanced research prospects and clinical practice, and the current taxonomy is, thus, a poor basis for biological research. The discussion proposes possible solutions to narrow this gap and to move psychiatric research forward towards personalized medicine.
BACKGROUND: Personalized medicine is a model in which a patient's unique clinical, genetic, and environmental characteristics are the basis for treatment and prevention. Aim, method, and results: This review aims to describe the current tools, phenomenological features, clinical risk factors, and biomarkers used to provide personalized medicine. Furthermore, this study describes the target areas in which they can be applied including diagnostics, treatment selection and response, assessment of risk of side-effects, and prevention. DISCUSSION AND CONCLUSION: Personalized medicine in psychiatry is challenged by the current taxonomy, where the diagnostic categories are broad and great biological heterogeneity exists within each category. There is, thus, a gap between the current advanced research prospects and clinical practice, and the current taxonomy is, thus, a poor basis for biological research. The discussion proposes possible solutions to narrow this gap and to move psychiatric research forward towards personalized medicine.
Authors: Jan Buitelaar; Sven Bölte; Daniel Brandeis; Arthur Caye; Nina Christmann; Samuele Cortese; David Coghill; Stephen V Faraone; Barbara Franke; Markus Gleitz; Corina U Greven; Sandra Kooij; Douglas Teixeira Leffa; Nanda Rommelse; Jeffrey H Newcorn; Guilherme V Polanczyk; Luis Augusto Rohde; Emily Simonoff; Mark Stein; Benedetto Vitiello; Yanki Yazgan; Michael Roesler; Manfred Doepfner; Tobias Banaschewski Journal: Front Behav Neurosci Date: 2022-07-06 Impact factor: 3.617
Authors: Ewa Kupcewicz; Elżbieta Grochans; Helena Kadučáková; Marzena Mikla; Aleksandra Bentkowska; Adam Kupcewicz; Anna Andruszkiewicz; Marcin Jóźwik Journal: J Pers Med Date: 2021-03-11
Authors: Anastasia Levchenko; Innokentiy S Losenkov; Natalia M Vyalova; German G Simutkin; Nikolay A Bokhan; Bob Wilffert; Anton Jm Loonen; Svetlana A Ivanova Journal: Pharmgenomics Pers Med Date: 2018-07-20